Terms: = Lung cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
332 results:
1. An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Levy A; Morel D; Texier M; Sun R; Durand-Labrunie J; Rodriguez-Ruiz ME; Racadot S; Supiot S; Magné N; Cyrille S; Louvel G; Massard C; Verlingue L; Bouquet F; Bustillos A; Bouarroudj L; Quevrin C; Clémenson C; Mondini M; Meziani L; Tselikas L; Bahleda R; Hollebecque A; Deutsch E
Mol Cancer; 2024 Mar; 23(1):61. PubMed ID: 38519913
[TBL] [Abstract] [Full Text] [Related]
2. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.
Xu H; Du Z; Li Z; Liu X; Li X; Zhang X; Ma J
Ann Med; 2024 Dec; 56(1):2313671. PubMed ID: 38325364
[TBL] [Abstract] [Full Text] [Related]
3. Attenuation of PI3K-Akt-mTOR Pathway to Reduce cancer Stemness on Chemoresistant lung cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor.
Huang YH; Chiu LY; Tseng JS; Hsu KH; Chen CH; Sheu GT; Yang TY
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203787
[TBL] [Abstract] [Full Text] [Related]
4. Estimating smoking-attributable lung cancer mortality in Chinese adults from 2000 to 2020: a comparison of three methods.
Ai F; Zhao J; Yang W; Wan X
BMC Cancer; 2024 Jan; 24(1):47. PubMed ID: 38195432
[TBL] [Abstract] [Full Text] [Related]
5. TGFβ1 induces CXCL1 to promote stemness features in lung cancer.
Peng TJ; Wu YC; Tang SJ; Sun GH; Sun KH
Exp Biol Med (Maywood); 2023 Dec; 248(23):2249-2261. PubMed ID: 38158808
[TBL] [Abstract] [Full Text] [Related]
6. Simplified Synthesis of Renieramycin T Derivatives to Target cancer Stem Cells via β-Catenin Proteasomal Degradation in Human lung cancer.
Ei ZZ; Racha S; Yokoya M; Hotta D; Zou H; Chanvorachote P
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132948
[TBL] [Abstract] [Full Text] [Related]
7. Metformin Suppresses Stemness of Non-Small-Cell lung cancer Induced by Paclitaxel through FOXO3a.
Tang Z; Zhang Y; Yu Z; Luo Z
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068934
[TBL] [Abstract] [Full Text] [Related]
8. pou5f1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6.
Yang W; Cui X; Sun D; Sun G; Yan Z; Wei M; Wang Z; Yu W
Cell Death Dis; 2023 Dec; 14(12):802. PubMed ID: 38062041
[TBL] [Abstract] [Full Text] [Related]
9. Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature.
Collins K; Ulbright TM; Davis JL
Diagn Pathol; 2023 Nov; 18(1):127. PubMed ID: 38031161
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological Features of Non-Small Cell lung Carcinoma with BRAF Mutation.
Ambrosini-Spaltro A; Rengucci C; Capelli L; Chiadini E; Calistri D; Bennati C; Cravero P; Limarzi F; Nosseir S; Panzacchi R; Valli M; Ulivi P; Rossi G
Curr Oncol; 2023 Nov; 30(11):10019-10032. PubMed ID: 37999148
[TBL] [Abstract] [Full Text] [Related]
11. What is the predictive value of RECIST criteria following stereotactic lung radiation?
Gulstene S; Lang P; Melody Qu X; Laba JM; Yaremko BP; Rodrigues GB; Yu E; Qiabi M; Nayak R; Malthaner RA; Fortin D; Warner A; Inculet RI; Palma DA
Radiother Oncol; 2024 Jan; 190():109976. PubMed ID: 37918636
[TBL] [Abstract] [Full Text] [Related]
12. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis.
Zhang Z; Qi D; Liu X; Kang P
Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792
[TBL] [Abstract] [Full Text] [Related]
13. LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation.
Zhang H; Jian J; Chen H; Zhu X; Xie J; Xu X
Pathol Res Pract; 2023 Aug; 248():154700. PubMed ID: 37473499
[TBL] [Abstract] [Full Text] [Related]
14. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1.
Chen J; Wu Z; Deng W; Tang M; Wu L; Lin N; Chen L; Fu Y; Zhao M; Chen C; Li W
J Transl Med; 2023 Jul; 21(1):453. PubMed ID: 37422632
[TBL] [Abstract] [Full Text] [Related]
15. Natural Cyclophilin A Inhibitors Suppress the Growth of cancer Stem Cells in Non-Small Cell lung cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.
Han JM; Kim SM; Kim HL; Cho HJ; Jung HJ
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298389
[TBL] [Abstract] [Full Text] [Related]
16. DNA-PKcs as an upstream mediator of oct4-induced MYC activation in small cell lung cancer.
Wei SJ; Yang IH; Mohiuddin IS; Kshirsagar GJ; Nguyen TH; Trasti S; Maurer BJ; Kang MH
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194939. PubMed ID: 37116859
[TBL] [Abstract] [Full Text] [Related]
17. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
[TBL] [Abstract] [Full Text] [Related]
18. Proteolytically degradable PEG hydrogel matrix mimicking tumor immune microenvironment for 3D co-culture of lung adenocarcinoma cells and macrophages.
Lee S; Ki CS
J Biomater Sci Polym Ed; 2023 Oct; 34(14):1981-1999. PubMed ID: 37071065
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer.
Niharika ; Roy A; Mishra J; Chakraborty S; Singh SP; Patra SK
Prog Mol Biol Transl Sci; 2023; 197():241-260. PubMed ID: 37019595
[TBL] [Abstract] [Full Text] [Related]
20. S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) inhibits lung cancer tumorigenesis by regulating cell plasticity.
Muñoz-Bernart M; Budnik N; Castro A; Manzi M; Monge ME; Pioli J; Defranchi S; Parrilla G; Santilli JP; Davies K; Espinosa JM; Kobayashi K; Vigliano C; Perez-Castro C
Biol Direct; 2023 Mar; 18(1):8. PubMed ID: 36872327
[TBL] [Abstract] [Full Text] [Related]
[Next]
